Boston Scientific prices $1.85B debt offering
Debt Financing
Apollo Endosurgery secures $50m loan
Apollo Endosurgery said it secured a $50 million term loan from Athyrium Capital Management it plans to use to refinance its debt.
CareFusion plans $1B debt offering
CareFusion (NYSE:CFN) said it plans to offer $1 billion worth of senior notes, aiming to use the proceeds to repay another, $450 million worth of senior debt that’s coming due this year.
Stryker readies $1B debt offering
Stryker (NYSE:SYK) said it’s planning to float $1 billion worth of senior notes as it refinances its debt load.
The Kalamazoo, Mich.-based medical device company said it’s pricing 2 sets of senior unsecured notes: $600 million, at 3.38% annually, due in May 2024; and $400 million, at 4.38%, due in May 2044.
TAVI: Direct Flow lands $50M through debt financing
California-based medtech company Direct Flow Medical landed $50 million in debt financing, planning on using the new funds to support commercialization of a new transcatheter aortic valve implantation system.
Battlefield wound tech company Arsenal Medical lands $4M
Arsenal Medical, a company that makes internal-bleeding control products for battlefield situations, brought in $4 million from 8 un-named investors in a funding round that opened last month.
Xlumena reels in $4.8M in debt financing
Xlumena closed a $4.8 million debt and securities round with 10 unnamed investors.
Founded in 2007, the Mountain View, Calif.-based company makes ultrasound-guided interventional microscopes, including an FDA-cleared pancreatic cyst access device called Navix.
Xlumena is wrapping up clinical trials to support a 510(k) application for its Axios stent and delivery system, also to treat pancreatic cysts.
Wright Medical announces $200M debt offering | Wall Street Beat
Wright Medical (NSDQ:WMGI) said it’s planning a private placement for $200 million worth of senior notes due 2017.
Standard & Poor’s gives Medtronic an A+ | Wall Street Beat
Standard & Poor’s Ratings Services affirmed Medtronic’s (NYSE:MDT) long-term debt’s “A+” rating yesterday, after the med-tech titan announced another debt offering.
The rating agency said its view of Medtronic’s senior unsecured notes and its stable rating outlook “reflect the company’s ‘strong’ business risk profile and ‘modest’ financial risk profile.”
Medtronic prices $1.1B senior notes offering
Med-tech titan Medtronic (NYSE:MDT) priced a debt offering worth $1.07 billion, saying it plans to use the funds for "general corporate purposes, which may include repayment of its indebtedness."
The Fridley, Minn.-based device maker offered $675 million in 3.125% senior notes due 2022 and $400 million of 4.5% senior notes due 2042, according to a press release.
Report: Covidien to acquire superDimension for $350M | Wall Street Beat
Covidien (NYSE:COV) is set to close a $350 million buyout of Israeli lung diagnosis firm superDimension by the end of the week, according to Israeli business journal Calcalist.
Founded in Tel Aviv by Pinchas Gilboa, Minneapolis-based superDimension, which employs about 120 people worldwide, also has offices in Dusseldorf, Germany.
